World

China grants nation’s first coronavirus vaccine patent to CanSino

China’s vaccine specialist CanSino Biologics Inc has gained a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, state media reported, citing paperwork from the nation’s mental property regulator.

China’s vaccine specialist CanSino Biologics Inc has gained a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, state media reported, citing paperwork from the nation’s mental property regulator.

It’s the first COVID-19 vaccine patent granted by China, state-owned newspaper Individuals’s Day by day reported on Sunday.

Read Also:  US: Cops shoot Black man 8 occasions leaving him paralyzed; protests in Wisconsin

The paper cited paperwork printed by China’s Nationwide Mental Property Administration saying that the patent was issued on Aug. 11.

Saudi Arabia stated this month it plans to start Part III medical trials for the CanSino vaccine. CanSino has stated it’s also in talks with Russia, Brazil and Chile to launch Part III trials in these international locations.

Read Also:  Joe Biden to put out imaginative and prescient for post-Trump America as he accepts Democratic nomination

CanSino’s Hong Kong shares rose round 14% in Monday’s morning session. Its Shanghai shares rose by 6.6% as of noon.

Shreya Sharma

Hey this is Shreya From ShoppersVila News. I'm a content creator belongs from Ranchi, India. For more info contact me [email protected]

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
error: Content is protected !!